Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

US Medical Suction Device Market

ID: MRFR/MED/11435-CR
100 Pages
Vikita Thakur
Last Updated: April 02, 2026

US Medical Suction Device Market Research Report Information by Medical Suction System (Surgical Suction Devices, Respiratory Tract Suction, Dental Surgical Suction Pump, Lab Vacuum Pump, and Accessories), by Portability (Handheld Suction Devices and Wall-Mounted Suction Devices), by Application (Airway Cleaning, Surgical Applications, Gynecology, and Others), by Type (Electrically Operated Devices, Battery-Powered Devices, Manually Operated Devices, and Others), by End User (Hospitals & Clinics, Ambulatory Surgical Centres, Homecare, and Others), and By Region (Americas, Europe, Asia-Pacific, and Middle East & Africa) - Forecast till 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

US Medical Suction Device Market Infographic
Purchase Options
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Region (USD Billion)
  49.     4.1.1 North America
  50.       4.1.1.1 US
  51.       4.1.1.2 Canada
  52.     4.1.2 Europe
  53.       4.1.2.1 Germany
  54.       4.1.2.2 UK
  55.       4.1.2.3 France
  56.       4.1.2.4 Russia
  57.       4.1.2.5 Italy
  58.       4.1.2.6 Spain
  59.       4.1.2.7 Rest of Europe
  60.     4.1.3 APAC
  61.       4.1.3.1 China
  62.       4.1.3.2 India
  63.       4.1.3.3 Japan
  64.       4.1.3.4 South Korea
  65.       4.1.3.5 Malaysia
  66.       4.1.3.6 Thailand
  67.       4.1.3.7 Indonesia
  68.       4.1.3.8 Rest of APAC
  69.     4.1.4 South America
  70.       4.1.4.1 Brazil
  71.       4.1.4.2 Mexico
  72.       4.1.4.3 Argentina
  73.       4.1.4.4 Rest of South America
  74.     4.1.5 MEA
  75.       4.1.5.1 GCC Countries
  76.       4.1.5.2 South Africa
  77.       4.1.5.3 Rest of MEA
  78. 5 SECTION V: COMPETITIVE ANALYSIS
  79.   5.1 Competitive Landscape
  80.     5.1.1 Overview
  81.     5.1.2 Competitive Analysis
  82.     5.1.3 Market share Analysis
  83.     5.1.4 Major Growth Strategy in the Healthcare
  84.     5.1.5 Competitive Benchmarking
  85.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  86.     5.1.7 Key developments and growth strategies
  87.       5.1.7.1 New Product Launch/Service Deployment
  88.       5.1.7.2 Merger & Acquisitions
  89.       5.1.7.3 Joint Ventures
  90.     5.1.8 Major Players Financial Matrix
  91.       5.1.8.1 Sales and Operating Income
  92.       5.1.8.2 Major Players R&D Expenditure. 2023
  93.   5.2 Company Profiles
  94.     5.2.1 Medtronic (US)
  95.       5.2.1.1 Financial Overview
  96.       5.2.1.2 Products Offered
  97.       5.2.1.3 Key Developments
  98.       5.2.1.4 SWOT Analysis
  99.       5.2.1.5 Key Strategies
  100.     5.2.2 Boston Scientific (US)
  101.       5.2.2.1 Financial Overview
  102.       5.2.2.2 Products Offered
  103.       5.2.2.3 Key Developments
  104.       5.2.2.4 SWOT Analysis
  105.       5.2.2.5 Key Strategies
  106.     5.2.3 Smiths Medical (US)
  107.       5.2.3.1 Financial Overview
  108.       5.2.3.2 Products Offered
  109.       5.2.3.3 Key Developments
  110.       5.2.3.4 SWOT Analysis
  111.       5.2.3.5 Key Strategies
  112.     5.2.4 Teleflex (US)
  113.       5.2.4.1 Financial Overview
  114.       5.2.4.2 Products Offered
  115.       5.2.4.3 Key Developments
  116.       5.2.4.4 SWOT Analysis
  117.       5.2.4.5 Key Strategies
  118.     5.2.5 ConvaTec (US)
  119.       5.2.5.1 Financial Overview
  120.       5.2.5.2 Products Offered
  121.       5.2.5.3 Key Developments
  122.       5.2.5.4 SWOT Analysis
  123.       5.2.5.5 Key Strategies
  124.     5.2.6 Halyard Health (US)
  125.       5.2.6.1 Financial Overview
  126.       5.2.6.2 Products Offered
  127.       5.2.6.3 Key Developments
  128.       5.2.6.4 SWOT Analysis
  129.       5.2.6.5 Key Strategies
  130.     5.2.7 Stryker (US)
  131.       5.2.7.1 Financial Overview
  132.       5.2.7.2 Products Offered
  133.       5.2.7.3 Key Developments
  134.       5.2.7.4 SWOT Analysis
  135.       5.2.7.5 Key Strategies
  136.     5.2.8 Becton Dickinson (US)
  137.       5.2.8.1 Financial Overview
  138.       5.2.8.2 Products Offered
  139.       5.2.8.3 Key Developments
  140.       5.2.8.4 SWOT Analysis
  141.       5.2.8.5 Key Strategies
  142.     5.2.9 Fisher & Paykel Healthcare (NZ)
  143.       5.2.9.1 Financial Overview
  144.       5.2.9.2 Products Offered
  145.       5.2.9.3 Key Developments
  146.       5.2.9.4 SWOT Analysis
  147.       5.2.9.5 Key Strategies
  148.   5.3 Appendix
  149.     5.3.1 References
  150.     5.3.2 Related Reports
  151. 6 LIST OF FIGURES
  152.   6.1 MARKET SYNOPSIS
  153.   6.2 NORTH AMERICA MARKET ANALYSIS
  154.   6.3 EUROPE MARKET ANALYSIS
  155.   6.4 APAC MARKET ANALYSIS
  156.   6.5 SOUTH AMERICA MARKET ANALYSIS
  157.   6.6 MEA MARKET ANALYSIS
  158.   6.7 KEY BUYING CRITERIA OF HEALTHCARE
  159.   6.8 RESEARCH PROCESS OF MRFR
  160.   6.9 DRO ANALYSIS OF HEALTHCARE
  161.   6.10 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  162.   6.11 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  163.   6.12 SUPPLY / VALUE CHAIN: HEALTHCARE
  164.   6.13 BENCHMARKING OF MAJOR COMPETITORS
  165. 7 LIST OF TABLES
  166.   7.1 LIST OF ASSUMPTIONS
  167.     7.1.1
  168.   7.2 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  169.     7.2.1
  170.   7.3 ACQUISITION/PARTNERSHIP
  171.     7.3.1

Healthcare Market Segmentation

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions